Arestat™ Protein Stabilization Technology
Arestat™ comprises two fundamentally different aspects of our platform stabilization technology. Both utilize excipients and buffers approved by the FDA and EMEA in an unconventional manner to achieve the desired stability.
Both platform technologies are available for licensing for applications involving therapeutic proteins, vaccines, medical devices and diagnostics.
Conferences & Events
Arecor will be attending the forthcoming events:
25-27 January 2010, Drug Delivery Partnerships, Orlando, FL, USA
The 14th Annual Conference of Drug Delivery Partnerships (DDP). An opportunity for the pharmaceutical and biopharmaceutical companies from all over the world to interact with those involved with the drug delivery industry. Arecor is sponsoring this event. Presentation by Tom Saylor.
3-7 May 2010, BIO 2010, Chicago, MI, USA
BIO 2010 is a meeting place for executives, investors, scientists, researchers, policy makers and journalists from around the world. Arecor will be active in the Business Partnering sessions as well as attending presentations and the Exhibition area.
17 – 21 May, BioProcess Europe, Vienna, Austria
Click on the icon to download Arecor presentations from the following events:
EventLocationDate 
BioProcess UKBrighton, UK27/11/2008
Biosimilars ConferencePhiladelphia, USA01/11/2008
Biosimilars ConferenceDublin01/06/2008
BioEurope SpringMadrid01/04/2008